MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 10,828 followers.

RT @KamravaMD: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer https://t.co/dbBwdU5Vnc 5y…

RT @KamravaMD: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer https://t.co/dbBwdU5Vnc 5y…

RT @KamravaMD: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer https://t.co/dbBwdU5Vnc 5y…

RT @KamravaMD: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer https://t.co/dbBwdU5Vnc 5y…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.